Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
Plos One|August 15, 2017
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control studyÁngela Domínguez, Pilar Ciruela, Sergi Hernández, et al.
Vaccines|July 19, 2020
Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective StudySergi Hernández, Encarna Navas, Ignacio Aznar-Lou, et al.
Frontiers in Microbiology|June 20, 2022
Characteristics of 24 SARS-CoV-2-Sequenced Reinfection Cases in a Tertiary Hospital in SpainBlanca Borras-Bermejo, Maria Piñana, Cristina Andrés, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2021
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipientsDavid Cucchiari, Natalia Egri, Marta Bodro, et al.
Emerging Microbes & Infections|November 29, 2021
A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)Cristina Andrés, Maria Piñana, Blanca Borràs-Bermejo, et al.
Human Vaccines & Immunotherapeutics|January 18, 2013
Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort studyRosa López-Gigosos, Magda Campins, María J Calvo, et al.
Emerging Infectious Diseases|April 21, 2022
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018Alba Mir-Cros, Albert Moreno-Mingorance, M Teresa Martín-Gómez, et al.
Open Respiratory Archives|April 15, 2024
[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases]Felipe Villar-Álvarez, Miguel Ángel Martínez-García, David Jiménez, et al.
Anales De Pediatria|October 1, 2020
[Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units]Alvaro Díaz-Conradi, Juan José García-García, Sebastià González Peris, et al.
Blood Advances|November 29, 2021
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignanciesMoraima Jiménez, Elisa Roldán, Candela Fernández-Naval, et al.
Pageof 19